Rating History for Edgewise Therapeutics (EWTX) by Raymond James

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/26/2026 Martin Auster Maintain Strong Buy
(N/A)
46.00
(N/A)
 
 
  Details